Us Bancorp \De\ Neogenomics Inc Transaction History
Us Bancorp \De\
- $75.6 Billion
- Q4 2024
A detailed history of Us Bancorp \De\ transactions in Neogenomics Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 1,885 shares of NEO stock, worth $18,058. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,885
Previous 1,815
3.86%
Holding current value
$18,058
Previous $26,000
19.23%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$188 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$136 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$62.5 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$59.1 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$59 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.21B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...